Balboa Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Balboa Wealth Partners's LLY Position: Q3 2026 in Review
Balboa Wealth Partners increased its Eli Lilly (LLY) stake by 15% in Q3 2026, buying an estimated $266K and bringing the position to 1,703 shares worth $1.97M. The position accounts for 0.26% of the portfolio, ranked #67.
Balboa Wealth Partners first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Balboa Wealth Partners held 1,703 shares of Eli Lilly worth $1.97M as of Q3 2026.
- Balboa Wealth Partners bought 225 Eli Lilly shares in Q3 2026, an estimated $266K.
- Eli Lilly made up 0.26% of Balboa Wealth Partners's portfolio in Q3 2026, its #67 holding.
- Balboa Wealth Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Balboa Wealth Partners's 13F filing for Q3 2026, filed 20 Oct 2026.